The Patent Finder

Activatable Cytokine Polypeptides and Methods of Use Thereof (2024)

Werewolf Therapeutics, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 12,617,829Activatable Cytokine Polypeptides and Methods of Use Thereof
In force
 · Low confidence
UsedRemaining
EMD Serono Research & Development Institute, Inc.In forceLow confidence
Application 17/028,643Activatable Cytokine Polypeptides and Methods of Use Thereof
Abandoned
Abandoned Mar 19, 2026
Werewolf Therapeutics, Inc.AbandonedAbandoned Mar 19, 2026
Application 18/312,245Activatable Cytokine Polypeptides and Methods of Use Thereof
EMD Serono, Inc.
Pending
Not granted
EMD Serono, Inc.PendingNot granted
Application 19/562,226Activatable Cytokine Polypeptides and Methods of Use Thereof
Pending
Not granted
EMD Serono Research & Development Institute, Inc.PendingNot granted
4 of 4 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
1 of these is in force and held by Werewolf Therapeutics, Inc..
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited